IP Library › Granted Patent US 8,030,445
Granted Patent B2
US 8,030,445 · App. 12/437,778 · Granted Oct 4, 2011

Glycopeptide derivative

Assignee: Theravance, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,030,445
App. No.
12/437,778
Granted
Oct 4, 2011
Kind
B2
Abstract

Disclosed are derivatives of glycopeptide compounds having at least one substituent of the formula: —R a —Y—R b —(Z) x where R a , R b , Y, Z and x are as defined, and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

Claims (2)

1. A compound of the formula:

or a pharmaceutically-acceptable salt thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033163/0031 →
Continuity (10)
Continuation 11977377 · Oct 24, 2007
Continuation 11405234 · Apr 17, 2006
Continuation 11128901 · May 13, 2005
Continuation 10092088 · Mar 6, 2002
Continuation 09470209 · Dec 22, 1999
Provisional Application 60113728 · Dec 23, 1998
Provisional Application 60129313 · Apr 14, 1999
Provisional Application 60164024 · Nov 4, 1999
Provisional Application 60169978 · Dec 10, 1999
Related Publication 20090215982A1 · Aug 27, 2009